New drugs for early Alzheimer’s disease may allow people to live without help for up to 39 additional months, a new study ...

The test could help identify one key Alzheimer's biomarker, tau protein, before it shows up in brain. Here's what experts say ...

Neurofibrillary tangles (NFTs) are a hallmark of Alzheimer’s disease, formed by the accumulation of tau protein into ...

A team of researchers from the Keck School of Medicine of USC has unlocked the details of a cellular pathway that triggers cellular inflammation and aging and is linked to Alzheimer's disease, ...

A groundbreaking study reveals how a rare combination of genetics, proteomics, and environmental factors may hold the key to ...

The authors define the “5 Love Languages,” (5LL), as: ...

A Cleveland Clinic expert explains the signs that indicate a dementia patient is nearing the end of their life.

Scientists develop groundbreaking dual-action drug RI-AG03 that targets toxic tau proteins in Alzheimer's disease, showing ...

New research suggests that wearing continuous glucose monitors could lower the risk of dementia. Experts discuss how symptoms can overlap between diabetes and dementia.

Scientists Identify Alzheimer's Disease-Protective Genetic Factors and ... candidate for tackling memory deficits in the early stages of the disease in rodents. Research shows that the drug ...